
OpinionFebruary 13, 2020
Cancer Therapy in 2020
The promise of host-response profiling
Ofer Sharon is a physician and entrepreneur with more than 20 years of experience in clinical research, pharmaceuticals and biotechnology. He has made vital contributions to the acceleration of personalized medicine and oncology drug development. Sharon is CEO of OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy.

Cancer Therapy in 2020
The promise of host-response profiling